Thromb Haemost 1962; 07(01): 048-069
DOI: 10.1055/s-0038-1655455
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

The Significance of the Hageman-Factor for the Effect of Wettable Surface on Thrombocytes[*]

J Jürgens
1   II. Med. Univ. Clinic frankfurt (M.) (Head: Prof. Dr. J. Frey)
› Author Affiliations
Further Information

Publication History

Publication Date:
21 June 2018 (online)

Summary

1. Disintegration of thrombocytes through contact with wettable surfaces — precipitated in the glass rotator in the form of platelet agglomeration — demands the presence of the Hageman-factor, prothrombin and the fibrinogen on the surface of the thrombocytes.

2. For the precipitation of platelet-agglomeration and -disintegration through contact with glass, activation of the complete preliminary phase of blood coagulation is not essential. The process also takes place in the absence of factors V, VIII, IX and X and possibly also without the influence of PTA.

3. On the basis of the present results it can therefore be assumed that disintegration of the thrombocytes through wettable surfaces is brought about by activation of the Hageman-factor on wettable surfaces alone. The activated Hageman-factor probably reacts directly with prothrombin, which leads to sufficient activation of thrombin to cause an increase in adhesiveness and agglomeration of the thrombocytes.

4. This especial thrombocyte disintegration sequence may proceed directly or indirectly. Calcium ions are not essential to either form. Herein lies the fundamental difference to the activation of factor IX through glass contact. Here the direct mechanism does not require calcium ions, whereas these are indispensable for indirect activation.

5. For the activation of the intrinsic system of the plasma, PTA as an intermediary product is most probably indispensable, whereas this is not the case for the precipitation of platelet disintegration through glass contact.

6. The reason why factor IX is not essential to the precipitation of platelet disintegration may be either that the process requires only traces of thrombin, or that disintegration of the platelets is induced already by intermediary products. The precipitation of this sequence through slightest traces of thrombin could be explained by the fact that the lack of antithrombin on the surface of the thrombocytes and the presence of platelet factors 2 and 4 exert a thrombin protecting and thrombin potentiating effect.

The observation that platelet disintegration through contact activation with glass surfaces takes place even in the presence of heparin does not contradict the assumption that this process is brought about via thrombin. Although complete activation of the preliminary phase is prevented, the Hageman-principle is nevertheless activated through surface contact and the larger distance between activated surface and intact platelets is bridged over by the fact that the activated principle is not influenced through the heparin milieu. As soon as it reaches the platelet surface, it can, on account of the thrombin protecting effect, react directly with prothrombin.

8. The results of our investigations suggest that, in extremely severe cases of hepatic cirrhosis, the case of the regularly observed disturbance in platelet function (agglomeration, adhesion, retraction of the thrombocytes and rotation thrombelastography) are due, or partly due, to a significant deficiency of the Hageman-factor.

We wish to express our thanks to the Deutsche Forschungsgemeinschaft, Bad Godesberg, for their support in our investigations.

* Dedicated to Prof. Dr. F. Hoff on the occasion of his 65th birthday.


 
  • Literatur

  • 1 Bordet J, Gengou O. Recherches sur la coagulation du sang. Ann. Inst. Pasteur Lille 1930; 17: 822
  • 2 Hirschboeck J. Delayed Blood Coagulation and Absence of Clot Retraction in Collodion Lined Vessels. Proc. Soc. exp. Biol. (N. Y.) 1940; 45: 122
  • 3 Lenggenhager K. über die Entstehung. Erkennung und Vermeidung der postoperativen Fernthrombose Thieme; Stuttgart: 1948
  • 4 Tocantins L. M. Influence of the contacting surface on the coagulability and anticephalin activity of normal and hemophilic plasma. Amer. J. Physiol 1945; 143: 67
  • 5 Fiala S. On the role of a protein inhibitor in the first stage of blood coagulation. Arch. int. Physiol 1951; 58: 386
  • 6 Lozner E. L, Taylor F. H, McDonald H. The effect of foreign surfaces on blood coagulation. J. clin. Invest 1942; 21: 241
  • 7 Quick A. J, Epstein E. Thromboplastic Activity in Human Blood. J. appl. Physiol 1952; 4: 840
  • 8 Conley C. L, Hartmann R. C, Morse W. I. The Clotting Behaviour of Human “Platelet-Free” Plasma: Evidence for the Existence of a “Plasma Thromboplastin”. J. clin. Invest 1949; 28: 340
  • 9 Ratnoff O. D, Conley C. L. The role of surface and of calcium in the coagulation of a globulin fraction of platelet-deficient plasma. Bull. Johns Hopk. Hosp 1951; 89: 245
  • 10 Hartmann C. R, Conley C. L, Lalley J. S. Studies on the initiation of blood coagulation. I. The relationship of platelets to the clot-promoting effect of glass surfaces. Bull. Johns Hopk. Hosp 1949; 85: 231
  • 11 Biggs R, Douglas A. S, Macfarlane R. G. The initial stages of blood coagulation. J. Physiol 1953; 122: 538
  • 12 Biggs R, Douglas A. S, Macfarlane R. G. Christmas disease. A condition previously mistaken for haemophilia. Brit. med. J 1952: 1378
  • 13 Ratnoff O. D, Colopy J. E. A familial hemorrhagic trait associated with a deficiency of a clot promoting fraction of plasma. J. clin. Invest 1955; 34: 602
  • 14 Ramont B, Singer K, Heller P, Zimmermann H. J. Hageman factor (HF) deficiency. Blood 1956; 11: 745
  • 15 Frick P. G, Hagen P. S. Severe coagulation defect without hemorrhagic symptoms caused by a deficiency of the fifth plasma thromboplastin precursor. J. Lab. clin. Med 1946; 47: 592
  • 16 Jim R. T. S, Goldfein S. Hageman-Trait (Hageman Factor Deficiency). Amer. J. Med 1957; 23: 824
  • 17 Soulier J. P, Wartelle O, Ménaché D. Hageman-Trait and PTA deficiency; the role of contact of blood with glass. Rev. franc. ét. clin. biol 1958; 3: 263
  • 18 Ratnoff O. D. A familial trait characterized by deficiency of a clot-promoting fraction of plasma. J. Lab. Clin. Med 1954; 44: 915
  • 19 Ratnoff O. D, Margolius A. Hageman-Trait: an asymptomatic disorder of blood coagulation. Trans. Ass. Amer. Physiol 1955; 68: 149
  • 20 Caen J, Bernard J. Déficit en facteur Hageman. Rev. Hémat 1958; 13: 154-162. 154-162 (1958)
  • 21 Johnston C. L, Ferguson J. H, O’Hanlon F. A. Surface activation of plasma clotting: a function of Hageman factor. Proc. Soc. exp. Biol. (N. Y.) 1958; 99: 197
  • 22 Larrieu M. J, Soulier J. P, Culot Y. Déficit en facteur Hageman. Sang 1957; 28: 152
  • 23 Margolius A, Ratnoff O. D. Observations on the hereditary nature of Hagemantrait. Blood 1956; 11: 565
  • 24 Ratnoff O. D, Rosenblum J. M. The role of Hageman factor in the initiation of clotting by glass. J. Lab. clin. Med 1956; 47: 592
  • 25 Loeliger E. A, Hensen A. Coagulation Studies in a Case of Hageman-Trait initial stages of blood coagulation. Thromb. Diath. haem 1960; 5: 187
  • 26 Soulier J. P, Larrieu M. J. Déficit en 3ème factor prothromboplastique plasmatique. Rapports entre le PTA et le facteur Hageman. Thromb Diath. haem 1958; 2: 1
  • 27 Haanen C, Hommes F, Benraad H, Morselt G. A Case of HagemanFactor Deficiency and a Method to Purify the Factor. Thromb. Diath. haem 1960; 5: 201
  • 28 Wright I. S, Koller F, Streuli F. New blood clotting factors. Thromb. Diath. haem. (Suppl.) IV 1960
  • 29 Rapaport S. I, Aas K, Owren P. A. The Effect of Glass upon the Activity of the Various Plasma Clotting Factors. J. clin. Invest 1955; 34: 9
  • 30 Soulier J.-P, Wartelle O, Ménaché D. Hageman-Trait and PTA Deficiency; the Role of Contact of Blood with Glass. Brit. J. Haemat 1959; 5: 121
  • 31 Margolis J. Initiation of blood coagulation by glass and related surfaces. J. Physiol 1957; 137: 95
  • 32 Margolis J. Hageman-factor in plasma foreign surface reactions. Nature (Lond.) 1958; 182: 1102
  • 33 Hardisty R. M, Margolis J. The role of Hageman-factor in the initiation of blood coagulation. Brit. J. Haemat 1959; 5: 203
  • 34 Haanen, Hommes, Benrad, Morselt A Case of Hageman-factor Deficiency and a Method the Purify the Factor. Thromb. Diath. haem 1960; 5: 201
  • 35 Egli H. PersÖnl. Mitteilung. — Zur Differenzierung und Kalziumabhängigkeit von Kontaktwirkung benetzbarer Oberflächen. Thromb. Diath. haem 1959; 3: 604
  • 36 Roskam J. 1. Symp. Fond. V. Baldacci, Madrid 1953. — 2. Symp. Fond. V. Baldacci, Seteais 1956. — 3. Symp. Fond. V. Baldacci, Formentor 1960. Ed. Omnia Medica, Pisa.
  • 37 Bounameaux Y. 2. Symp. Fond. V. Baldacci, Seteais 1956. Ed. Omnia Medica, Pisa.
  • 38 Owren P. II. Symp. Fond. V. Baldacci, Seteais 1956. — III. Symp. Fond. V. Baldacci, Formentor 1960. Ed. Omnia Medica, Pisa.
  • 39 Salmon J, Bounameaux Y. études immunoélectrophorétiques des antigènes plaquettaires humains. C. R. Soc. Biol. (Paris) 1956; 150: 2278
  • 40 Seligmann M. B. et al. études immunochimiques sur la présence de fibrinogène dans les extraits de plaquettes humaines lavées et dans certains extraits leucocytaires. Rev. Hémat 1957; 12: 302
  • 41 Lüscher E. F. Thrombozytenfaktoren Ergebn. Physiol 1959; 50: 1
  • 42 Sokal G. Plaquettes Sanguines Et Structure Du Caillot. Ed. S. A. Arsia; Bruxelles: 1960
  • 43 Bounameaux Y. Sur Le Mécanisme De La Rétraction Du Caillot Et De La Métamorphose Visqueuse Des Plaquettes. Rev. Hémat 1957; 12: 16
  • 44 Johnson S. H, Schneider Ch. L. The existence of antifibrinolysin activity in platelets. Science 1953; 117: 229
  • 45 Wright H. P. The adhesiveness of blood platelets in normal subjects with varying concentrations of anticoagulants. Lancet 1956: 306
  • 46 Jürgens J, Beller F. K. Klinische Methoden der Blutgerinnungsanalyse. Thieme; Stuttgart: 1959
  • 47 Macfarlane R. G. A simple method for measuring clot retraction. Lancet 1939: 199
  • 48 Hartert H. Die Thrombelastographie. Eine Methode zur physikalischen Analyse des Blutgerinnungsvorganges. 2. ges. exp. Med 1951; 117: 189
  • 49 Hitzig W. H. Neue Methode zur Thrombozytenisolierung. Schweiz. med. Wschr 1954: 1126
  • 50 Soulier J.P. Fractions Coagulantes Préparées— A Partir Du Plasma Humain. Path. Biol 1959; 7: 2439
  • 51 Egli H, Buscha H. Zur Differenzierung und Kalziumabhängigkeit von Kontaktwirkungen benetzbarer Oberflächen. Ihr Einfluß auf die Blutthrombokinasebildung. Thromb. Diath. haem 1954; 3: 604
  • 52 Biggs R, Douglas A. S, Macfarlane R. G. The formation of thromboplastin in human blood. J. Physiol 1953; 119: 89
  • 53a Jürgens J. II. Symp. Fond. V. Baldacci, Seteais. 1957. Ed. Omnia Medica; Pisa.:
  • 53b Jürgens J. III. Symp. Fond. V. Baldacci, Formentor, Mallorca. 1960. Ed. Omnia Medica; Pisa:
  • 53c Jürgens J. Symp. on Platelets. Henry Ford-Hosp; Detroit: 1960
  • 53d Jürgens J. über die Ursache der Blutungsneigung bei der Makroglobulinämie WaldenstrÖm. Verh. dtsch. Ges. inn. Med., 62. Kongr. 1956
  • 54 Ollendorff P. Platelet Activity and Activation of Blood Clotting by Glass. Thromb. Diath. haem 1960; 4: 410
  • 55 Marx R. Zur Trennung thrombozytogener und thrombozytotroper Gerinnungsfaktoren. Proc. VII Congr. Intern. Soc. Blood Transf., Rom 1958